How Policy Shifts Could Expand Obesity Drug Coverage A major barrier preventing widespread access to GLP-1 medications is the lack of insurance coverage, especially for weight loss
These reactions are usually mild and go away on their own
Dermal Fillers Injectable hyaluronic acid-based fillers can restore lost volume in the cheeks, under the eyes, and around the mouth
Prescription GLP-1 receptor agonists may be indicated for adults with type 2 diabetes not meeting glycemic targets, those with established cardiovascular disease or chronic kidney disease, or individuals with obesity and weight-related complications when lifestyle interventions prove insufficient
None of the analyses demonstrated an increased risk of PDAC associated with GLP-1RA 35,36,37 (Table 1)
Medication dosage should never be adjusted without consulting the prescribing provider. Resources We Trust Cleveland Clinic: Ozempic for Weight Loss: Who Should Try It and Will It Work